Insider Transactions in Q1 2022 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
Aaron I. Davis |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.62%
|
$640,000
$32.85 P/Share
|
|
Mar 22
2022
|
Aaron I. Davis |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.31%
|
$960,000
$32.8 P/Share
|
|
Mar 22
2022
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,437
-12.02%
|
$626,858
$34.82 P/Share
|
|
Mar 17
2022
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
575,201
-15.47%
|
$20,132,035
$35.25 P/Share
|
|
Mar 11
2022
|
Michel Detheux Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+18.28%
|
-
|
|
Mar 11
2022
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$126,000
$36.01 P/Share
|
|
Mar 11
2022
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$14,000
$4.3 P/Share
|
|
Mar 01
2022
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$360,000
$36.76 P/Share
|
|
Mar 01
2022
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$40,000
$4.24 P/Share
|
|
Feb 23
2022
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,500
-14.95%
|
$493,000
$34.81 P/Share
|
|
Feb 11
2022
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-78.31%
|
$122,500
$35.9 P/Share
|
|
Feb 11
2022
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$14,000
$4.3 P/Share
|
|
Jan 25
2022
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,500
-12.03%
|
$507,500
$35.83 P/Share
|
|
Jan 14
2022
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-89.67%
|
$136,500
$39.42 P/Share
|
|
Jan 14
2022
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$14,000
$4.3 P/Share
|
|
Jan 05
2022
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,135
-0.66%
|
$761,670
$42.03 P/Share
|
|
Jan 05
2022
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,135
-0.66%
|
$761,670
$42.03 P/Share
|
|
Jan 05
2022
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,347
-0.67%
|
$1,274,574
$42.03 P/Share
|
|
Jan 04
2022
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
128,550
-1.12%
|
$5,656,200
$44.26 P/Share
|
|
Jan 04
2022
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
128,550
-1.12%
|
$5,656,200
$44.26 P/Share
|
|
Jan 04
2022
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
215,122
-1.15%
|
$9,465,368
$44.26 P/Share
|
|
Jan 04
2022
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
184,677
-33.45%
|
$7,941,111
$43.78 P/Share
|
|
Jan 03
2022
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
515,323
-8.12%
|
$25,250,827
$49.21 P/Share
|
|
Jan 03
2022
|
Detlev Biniszkiewicz Director |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$178,500
$51.9 P/Share
|
|
Jan 03
2022
|
Detlev Biniszkiewicz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$66,500
$19.0 P/Share
|
|
Jan 03
2022
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$357,000
$51.9 P/Share
|
|
Jan 03
2022
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$28,000
$4.3 P/Share
|